SBC
SBC Medical GroupCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The constructive case is balance-sheet-backed optionality: SBC ended 2025 with substantial cash, no immediate stated liquidity gap, and an authorized buyback that could become a signaling tool if management starts using it meaningfully. [#10-K-2026-03-27]
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Disclosure controls were not effective as of December 31, 2025 because material weaknesses in internal control over financial reporting had not been fully remediated. [#10-K-2026-03-27]
Momentum
21
Value
73
Sentiment
56
Setup hits (3d)
— · Net —
AI TargetsBase $3.10 · Bull $4.60 · Bear $2.10
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net —
Target $8.50
Why
Momentum21 · Δ7d -
Value73 · Δ7d +0.0
Sentiment56 · Δ7d -
So what
Balanced signals. Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
21
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
73
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.4
Sentiment
56
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 20.6 / Value 72.9 / Sentiment 56.4
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$316.77M
Beta
1.13
Shares Out
102.85M
P/E (TTM)
10.7
P/S (TTM)
2.59
P/FCF (TTM)
26.88
Rev YoY
-9.0%
EPS YoY
-47.1%
Gross Margin
+69.9%
Op Margin
+38.2%
Net Debt
-$112.46M
Current Ratio
3.82
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology